Hongtao Lei

Hongtao Lei

Auto-generated profile, based on publicly available information

Hongtao Lei

School of Public Health & School of Basic Medical Sciences, Kunming Medical University, Kunming, Yunnan, 650500, People’s Republic of China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2022 in Disease Markers
Verified
Journal Article
Open access
PDF file
LXLi Xue
Li Xue
SSShulan Shi
Shulan Shi
HLHongtao Lei
Hongtao Lei
ZZZhen Zhang
Zhen Zhang
XTXin Tian
Xin Tian
HJHongchao Jiang
Hongchao Jiang
Semaphorin 4D (Sema4D) is highly expressed in various cancers and leukemia. It is involved in the development of acute leukemia. A high level of soluble Sema4D is also present in the plasma of acute leukemia patients. However, it remains unknown whether Sema4D is associated with the clinical characteristics of acute leukemia. In this study, Sema4D expression was examined in peripheral blood mononuclear cells (PBMCs) and bone marrow mononuclear cells (BMMCs) of patients with acute leukemia, and it was highly expressed in the PBMCs of B-acute lymphoblastic leukemia (ALL), T-ALL, and acute myeloid leukemia (AML) patients and in the BMMCs of B-ALL and AML patients but not in the BMMCs of T-ALL patients. Sema4D expression was higher in the PBMCs of T-ALL patients than in the PBMCs of B-ALL or AML patients. In addition, Sema4D expression in BMMCs was reduced in B-ALL patients during the chemotherapy process. It was lower in remission patients than in newly diagnosed and patients without remission. In acute leukemia, soluble Sema4D level in serum is positively correlated with Sema4D expression in PBMCs, leukocyte number, and peripheral blast number. Those results suggest that the levels of Sema4D and its soluble form are associated with acute leukemia development and may be regarded as a potential biomarker in pediatric acute leukemia.

22 September 2026 in JMIR Medical Informatics
Verified
Journal Article
Open access
LSLixuan Song
Lixuan Song
SZSiwen Zhao
Siwen Zhao
YDYuanzheng Deng
Yuanzheng Deng
RYRuqin Yang
Ruqin Yang
HWHongyang Wang
Hongyang Wang
TGTaipin Guo
Taipin Guo
Background: Orthopedic surgery is the second most common subspecialty involved in medical malpractice claims, wherein lower limb surgery carries a higher risk of claims and involves higher compensation amounts. However, effective tools for postjudgment estimation of high compensation ratios and consistency assessment against prior similar cases after lower limb fracture surgery are currently lacking in medicolegal risk management and judicial practice. Objective: This study aimed to develop and validate multiple machine learning (ML) models to estimate a medical malpractice compensation ratio of ≥50% in postjudgment, nonfinalized medicolegal cases, and to systematically evaluate the models’ discriminative ability, stability, calibration performance, and medicolegal utility. Methods: This study developed binary classification models based on 451 medical malpractice cases after lower limb fracture surgery in China from 2004 to 2025. Among these cases, 360 cases from eastern, northeastern, and central China constituted the development dataset and were randomly split at a 7:3 ratio into a training set (n=251) and an internal test set (n=109), whereas 91 cases from western China were held out as an independent geographical external validation set. Least Absolute Shrinkage and Selection Operator (LASSO) was used for feature selection. Logistic regression (LR), k-nearest neighbors (KNN), support vector machine (SVM), random forest (RF), and extreme gradient boosting (XGBoost) were trained using 5-fold cross-validation and grid search. Model performance was assessed using the receiver operating characteristic (ROC) curve, area under the receiver operating characteristic curve (AUROC), bootstrap resampling, calibration curves, and decision curve analysis (DCA). Results: LASSO identified following 8 predictors: inappropriate surgical procedure, age, inadequate medical records, lack of informed consent, disability severity grade 1-4, sex, treatment delay, and inadequate preoperative preparation. In the test set, the LR model achieved an AUROC of 0.933, with recall, precision, accuracy, and F1-score of 0.810, 0.940, 0.872, and 0.870, respectively. Inappropriate surgical procedure and lack of informed consent were the strongest model-associated factors. Bootstrap analysis showed stable LR discrimination, and calibration was favorable, with a Brier score of 0.105. DCA suggested a potential reference value across threshold probabilities. Considering discrimination, calibration, classification performance, parsimony, and interpretability, the LR model was selected as the final model. External validation provided preliminary support for cross-regional transportability. Conclusions: ML-based models for postjudgment estimation may provide a nonbinding historical benchmark for estimating whether a compensation ratio of ≥50% is broadly consistent with previous similar cases in medical malpractice claims. Notably, the LR model showed the most favorable overall performance among the compared models in terms of discriminative ability, stability, calibration, and medicolegal utility, providing an auxiliary postjudgment reference for hospital risk management and legal departments, legal practitioners, courts, and other judicial professionals before a case becomes final or is practically concluded. Trial Registration: OSF Registries 10.17605/OSF.IO/EMAKT; https://osf.io/emakt/overview

1 June 2026 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
MHMan Huang
Man Huang
ADAn Dai
An Dai
LGLiufei Gao
Liufei Gao
CWChanghui Wu
Changhui Wu
WZWen Zou
Wen Zou
HLHongtao Lei
Hongtao Lei
Background: Chronic liver disease progression is closely linked to systemic inflammatory responses and nutritional status. This study aimed to evaluate the prognostic value of the Glasgow Prognostic Score (GPS) system for predicting recompensation in patients with decompensated primary biliary cholangitis (PBC). Methods: This multicenter, retrospective cohort study enrolled patients with decompensated PBC admitted to seven hospitals between January 2014 and December 2023. The GPS, mGPS, and hs-mGPS were determined according to baseline CRP, hs-CRP, and ALB levels. The primary endpoint was the achievement of recompensation during follow-up (defined as biochemical response to UDCA, resolution of decompensating events, and stable improvement in liver function per Baveno VII criteria). Results: Of the 504 patients with decompensated PBC analyzed, the median age was 62 years (IQR: 53– 69) and 81.5% (n=411) were women. Over a median follow-up of 31 months (IQR: 14– 56), recompensation occurred in 136 patients (27.0%). Kaplan-Meier analysis confirmed that higher GPS, mGPS, and hs-mGPS scores were associated with lower 5-year recompensation rates (all P < 0.0001). Cox regression analysis revealed that in the fully adjusted model, GPS (HR: 0.311, 95% CI: 0.219– 0.444), mGPS (HR: 0.302, 95% CI: 0.188– 0.487), and hs-mGPS (HR: 0.351, 95% CI: 0.248– 0.496) were all independent predictors for recompensation. Time-dependent ROC analysis showed that the AUCs for predicting recompensation were 0.888 for GPS, 0.795 for mGPS, and 0.871 for hs-mGPS, indicating the best predictive performance for GPS. Sensitivity and subgroup analyses confirmed the robustness of these findings. Conclusion: The GPS and its variants reliably predict recompensation in decompensated PBC, with the GPS showing superior accuracy. These tools can stratify risk and inform early intervention strategies.

19 February 2026 in JMIR Preprints
Verified
Preprint
Open access
LSLixuan Song
Lixuan Song
SZSiwen Zhao
Siwen Zhao
YDYuanzheng Deng
Yuanzheng Deng
RYRuqin Yang
Ruqin Yang
HWHongyang Wang
Hongyang Wang
TGTaipin Guo
Taipin Guo
BACKGROUND Orthopedic surgery is the second most common subspecialty involved in medical malpractice claims, wherein lower limb surgery carries a higher risk of claims and involves higher compensation amounts. However, effective tools for postjudgment estimation of high compensation ratios and consistency assessment against prior similar cases after lower limb fracture surgery are currently lacking in medicolegal risk management and judicial practice. OBJECTIVE This study aimed to develop and validate multiple machine learning (ML) models to estimate a medical malpractice compensation ratio of ≥50% in postjudgment, nonfinalized medicolegal cases, and to systematically evaluate the models’ discriminative ability, stability, calibration performance, and medicolegal utility. METHODS This study developed binary classification models based on 451 medical malpractice cases after lower limb fracture surgery in China from 2004 to 2025. Among these cases, 360 cases from eastern, northeastern, and central China constituted the development dataset and were randomly split at a 7:3 ratio into a training set (n=251) and an internal test set (n=109), whereas 91 cases from western China were held out as an independent geographical external validation set. Least Absolute Shrinkage and Selection Operator (LASSO) was used for feature selection. Logistic regression (LR), k-nearest neighbors (KNN), support vector machine (SVM), random forest (RF), and extreme gradient boosting (XGBoost) were trained using 5-fold cross-validation and grid search. Model performance was assessed using the receiver operating characteristic (ROC) curve, area under the receiver operating characteristic curve (AUROC), bootstrap resampling, calibration curves, and decision curve analysis (DCA). RESULTS LASSO identified following 8 predictors: inappropriate surgical procedure, age, inadequate medical records, lack of informed consent, disability severity grade 1-4, sex, treatment delay, and inadequate preoperative preparation. In the test set, the LR model achieved an AUROC of 0.933, with recall, precision, accuracy, and F1-score of 0.810, 0.940, 0.872, and 0.870, respectively. Inappropriate surgical procedure and lack of informed consent were the strongest model-associated factors. Bootstrap analysis showed stable LR discrimination, and calibration was favorable, with a Brier score of 0.105. DCA suggested a potential reference value across threshold probabilities. Considering discrimination, calibration, classification performance, parsimony, and interpretability, the LR model was selected as the final model. External validation provided preliminary support for cross-regional transportability. CONCLUSIONS ML-based models for postjudgment estimation may provide a nonbinding historical benchmark for estimating whether a compensation ratio of ≥50% is broadly consistent with previous similar cases in medical malpractice claims. Notably, the LR model showed the most favorable overall performance among the compared models in terms of discriminative ability, stability, calibration, and medicolegal utility, providing an auxiliary postjudgment reference for hospital risk management and legal departments, legal practitioners, courts, and other judicial professionals before a case becomes final or is practically concluded. CLINICALTRIAL OSF Registries 10.17605/OSF.IO/EMAKT; https://osf.io/emakt/overview